Current breast cancer predictive signatures are not unique. Can we use this fact to our advantage to improve prediction? From the machine learning perspective, it is well known that combining multiple classifiers can improve classification performance. We propose an ensemble machine learning approach which consists of choosing feature subsets and learning predictive models from them. We then combine models based on certain model fusion criteria and we also introduce a tuning parameter to control sensitivity. Our method significantly improves classification performance with a particular emphasis on sensitivity which is critical to avoid misclassifying poor prognosis patients as good prognosis.Peer reviewed: YesNRC publication: Ye
BackgroundBiomarkers are a key component of precision medicine. However, full clinical integration o...
Nowadays, breast cancer is reported as one of most common cancers amongst women. Early detection of ...
BACKGROUND:Biomarkers are a key component of precision medicine. However, full clinical integration ...
Breast cancer is still a major worldwide health issue, highlighting the demand for accurate prognost...
Breast cancer (BC) is the second most prevalent type of cancer among women leading to death, and its...
Breast cancer is the most frequently encountered medical hazard for women in their forties, affectin...
Abstract: According to WHO, breast cancer is the disease that affects people the most frequently and...
This paper presents a classifier ensemble approach for predicting the survivability of the breast ca...
Today’s world faces a serious public health problem with cancer. One type of cancer that begins in t...
In this paper, we describe a dataset relating to cellular and physical conditions of patients who ar...
Breast cancer which is the second most frequent form of cancer in females around the world after ski...
The rise of machine learning (ML) has recently buttressed the efforts for big data-driven precision ...
Accurate and early diagnosis of breast cancer increases survival rate of patients. Diagnosis of Brea...
Background: Breast cancer, behind skin cancer, is the second most frequent malignancy among women, i...
Breast cancer is the most dreadful disease in the world in past few decades. Many women in the world...
BackgroundBiomarkers are a key component of precision medicine. However, full clinical integration o...
Nowadays, breast cancer is reported as one of most common cancers amongst women. Early detection of ...
BACKGROUND:Biomarkers are a key component of precision medicine. However, full clinical integration ...
Breast cancer is still a major worldwide health issue, highlighting the demand for accurate prognost...
Breast cancer (BC) is the second most prevalent type of cancer among women leading to death, and its...
Breast cancer is the most frequently encountered medical hazard for women in their forties, affectin...
Abstract: According to WHO, breast cancer is the disease that affects people the most frequently and...
This paper presents a classifier ensemble approach for predicting the survivability of the breast ca...
Today’s world faces a serious public health problem with cancer. One type of cancer that begins in t...
In this paper, we describe a dataset relating to cellular and physical conditions of patients who ar...
Breast cancer which is the second most frequent form of cancer in females around the world after ski...
The rise of machine learning (ML) has recently buttressed the efforts for big data-driven precision ...
Accurate and early diagnosis of breast cancer increases survival rate of patients. Diagnosis of Brea...
Background: Breast cancer, behind skin cancer, is the second most frequent malignancy among women, i...
Breast cancer is the most dreadful disease in the world in past few decades. Many women in the world...
BackgroundBiomarkers are a key component of precision medicine. However, full clinical integration o...
Nowadays, breast cancer is reported as one of most common cancers amongst women. Early detection of ...
BACKGROUND:Biomarkers are a key component of precision medicine. However, full clinical integration ...